Selcaxen 40mg (Selpercatinib) is an oral medication used to treat certain types of cancers, specifically those with rearranged during transfection (RET) gene alterations. It is primarily indicated for treating non-small cell lung cancer (NSCLC), medullary thyroid cancer, and other thyroid cancers that harbor RET mutations or fusions. Selpercatinib works by selectively inhibiting the RET kinase, thereby blocking cancer cell growth and proliferation.
https://iebpharma.com/product/....selcaxen-40mg-selper